TJ

Tulika Jain

Active Director Director DIN 06879268
DIN 06879268 First appointment Dec 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Tulika Jain

Data last updated:

Tulika Jain is a Director at Edison Organics Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Edison Organics Pharmaceuticals Private Limited reported revenue of ₹89.9 Lakh (FY 2025).

DIN 06879268
Primary Designation Director
Industry Pharma
First Appointment 09 Dec 2019
Oldest Company Age 14 yrs
Largest company Edison Organics Pharmaceuticals Private Limited · ₹89.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Dec 20192012₹89.9 Lakh (FY 2025)Active

Board colleagues of Tulika Jain

Directorship timeline

Open interactive timeline →
Edison Organics Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tulika Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tulika Jain

Tulika Jain currently holds 1 directorship: Edison Organics Pharmaceuticals Private Limited (Director, since 09 Dec 2019, revenue ₹89.9 Lakh (FY 2025)).

Tulika Jain was first appointed on 09 Dec 2019 as Director at Edison Organics Pharmaceuticals Private Limited.

The current boards of Tulika Jain's companies include Aakash Jain (Edison Organics Pharmaceuticals Private Limited), Parminder Singh (Edison Organics Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available